Media
Media Contact
Financial & General Press
Henri von Haartman
Director of Investor Relations
+46 768 665 011
+358 29 370 0150
hvh@nanoform.com
Henri von Haartman
Director of Investor Relations
+46 768 665 011
+358 29 370 0150
hvh@nanoform.com
Pharmaceutical Press
Christian Jones
Chief Commercial Officer
+44 7804 474 771
+358 29 370 0150
christian.jones@nanoform.com
Christian Jones
Chief Commercial Officer
+44 7804 474 771
+358 29 370 0150
christian.jones@nanoform.com
Press releases
-
Non Regulatory September 9, 2021Nanoform technology delivers successful results for Herantis CDNF drug candidate
-
Regulatory August 27, 2021The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees
-
Regulatory August 26, 2021Nanoform Interim Report January – June 2021